Amplimed Corporation
529-1000
www.amplimed.com

AmpliMed® Corporation, a clinical-stage pharmaceutical company founded by world-renowned oncologists, has a lead compound, Amplimexon®, in Phase II clinical trials, with early evidence of efficacy and low levels of toxicity. The Company also has two other promising drug candidates, benzimate, which entered Phase I clinical study during 2006, and Amplizone™, which is scheduled to begin Phase I studies in 2007. The Company is focused on the development of small-molecule oncology drugs with novel mechanisms of action.

Vision NOW
299-4100
www.optometrists.org/visionnow

At Vision NOW, our passion has inspired us to create a "state of the art" Vision Therapy program that integrates the best of what Developmental Optometry, Naturopathic Medicine and Neuro-Optometric Rehabilitation have to offer. We specialize in helping children with learning issues at school.